AML
News
Social factors may impact survival in AML
Photo by Rhoda Baer A new study indicates that certain social factors may impact survival in adults with acute myelogenous leukemia (AML) who are...
News
Drug granted orphan designation for AML
Image by Lance Liotta The investigational therapy SL-401 has received orphan designation to treat acute myeloid leukemia (AML) in the European...
News
T-cell exhaustion may be therapeutic target for AML
Image courtesy of NIAID New research has revealed a population of T cells associated with relapse of acute myeloid leukemia (AML) after...
News
Targeting STAT3 to prevent relapse in AML
Compounds that target a novel binding site on STAT3 may one day be used to prevent relapse in acute myeloid leukemia (AML), according to...
News
Groups crowd-source cancer research
Photo by Rhoda Baer In an attempt to crowd-source cancer research, a pair of Canadian organizations made a small molecule they developed freely...
News
Agent blocks STAT3 protein and might prevent AML relapse
News
Persistent mutations tied to relapse, death in AML
Mutations that persist after initial chemotherapy may confer an increased risk of relapse and poor survival in patients with acute myeloid...
News
Persistent mutations linked to poorer outcomes in AML
Key clinical point: Leukemia-associated mutations that persisted 30 days after chemotherapy initiation were associated with a significantly...
News
Outcomes worse with secondary and therapy-related AML compared with de novo AML
Key clinical point: Younger patients with secondary and therapy-related acute myeloid leukemia (sAML and tAML, respectively) have worse outcomes...
News
New HMA shows early promise for MDS/AML
Image by Christoph Bock Investigators say a novel hypomethylating agent (HMA) is safe and clinically active in patients with myelodysplastic...
News
Selinexor dose lowered due to sepsis in AML patients
Photo by Esther Dyson An excess of sepsis cases has prompted dose reductions in a phase 2 trial of selinexor in older patients with relapsed/...